Cardiovirus Leader (L) proteins induce potent antihost inhibition of active cellular nucleocytoplasmic trafficking by triggering aberrant hyperphosphorylation of nuclear pore proteins (Nup). To achieve this, L binds protein RanGTPase (Ran), a key trafficking regulator, and diverts it into tertiary or quaternary complexes with required kinases. The activity of L is regulated by two phosphorylation events not required for Ran binding. Matched NMR studies on the unphosphorylated, singly, and doubly phosphorylated variants of Mengovirus L (L M ) show both modifications act together to partially stabilize a short internal α-helix comprising L M residues 43-46. This motif implies that ionic and Van der Waals forces contributed by phosphorylation help organize downstream residues 48-67 into a new interface. The full structure of L M as bound to Ran (unlabeled) and Ran (216 aa) as bound by L M (unlabeled) places L M into the BP1 binding site of Ran, wrapped by the conformational flexible COOH tail. The arrangement explains the tight K D for this complex and places the L M zinc finger and phosphorylation interface as surface exposed and available for subsequent reactions. The core structure of Ran, outside the COOH tail, is not altered by L M binding and remains accessible for canonical RanGTP partner interactions. Pull-down assays identify at least one putative Ran:L M partner as an exportin, Crm1, or CAS. A model of Ran:L M :Crm1, based on the new structures suggests L M phosphorylation status may mediate Ran's selection of exportin(s) and cargo(s), perverting these native trafficking elements into the lethal antihost Nup phosphorylation pathways.
Solution structures of Mengovirus Leader protein, its phosphorylated derivatives, and in complex with nuclear transport regulatory protein, RanGTPase Edited by Bert L. Semler, University of California, Irvine, CA, and accepted by the Editorial Board September 24, 2014 (received for review June 13, 2014) Cardiovirus Leader (L) proteins induce potent antihost inhibition of active cellular nucleocytoplasmic trafficking by triggering aberrant hyperphosphorylation of nuclear pore proteins (Nup). To achieve this, L binds protein RanGTPase (Ran), a key trafficking regulator, and diverts it into tertiary or quaternary complexes with required kinases. (1) . Common to all isolates, the single-stranded, positivesense RNA genome is characterized by a long ORF encoding 10-14 concatenated protein-coding genes. The replication cycle initiates as soon as this ORF is translated, and the resulting polyprotein is processed (co-and posttranslationally) into the required active components, which include seven to eight nonstructural proteins (NSPs) and three to four capsid proteins designated according to a standard "L-4-3-4" nomenclature (2) . The Leader (L) proteins, when present, precede the capsid proteins (1ABCD) and all of the other NSPs (2ABC and 3ABCD). Most NSPs have vital roles in viral replication, but the L and 2A proteins are key determinants for antihost responses. The specific genes at these locales vary significantly among the genera and even among otherwise related species.
Unique to isolates in the Cardiovirus genus, the Leader gene encodes a small [67-76 amino acids (aa)] highly acidic protein (pI, 3.2-3.6) with very unusual properties. When L is expressed in cells by viral or recombinant introduction, it binds tightly (3 nM K D ) with 1:1 stoichiometry to the nuclear transport regulator, RanGTPase (3) . Ran, a member of the Ras superfamily of GTPases, normally alternates between nuclear GTP-and cytoplasmic GDP-bound conformers, acting as a molecular switch for the coordinated transport of large molecules back and forth through the nuclear pores (4) . However, when L binds Ran, the perverted complex recruits and activates a specific cohort of cellular kinases responsible for the L-induced hyperphosphorylation of Phe/Gly-containing nuclear pore proteins (Nups) (5) (6) (7) (8) . The consequence is rapid, potent inhibition of active nuclear-cytoplasmic trafficking. Because picornaviruses replicate in the cytoplasm, this inhibition is detrimental only to the cell. Among the measured results, there is antagonism of IFN transcription (9) (10) (11) (12) , impediment of cellular stress granule formation (13) , and retention of cellular mRNA transcripts in the nucleus (12) . These cumulative activities allow cardioviruses to negate almost all host antiviral innate immune responses and enhance their pathogenicity during infection.
The best studied L proteins, representing the Encephalomyocarditis virus (EMCV) species, are from EMCV-R (L E ) and Mengovirus (L M ) isolates. The species as a whole shares ∼95% identity here, but these strains differ by a single substitution (L 14 M) in the 67-aa protein length (Fig. 1A) . The change is in a conserved, amino-proximal CHCC zinc finger motif (aa [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , the structure of which was determined by NMR for the L M protein (14) . Technical difficulties hampered resolution of the complete protein, but a full coordinate set was recently completed [Protein Data Bank (PDB) ID code 2M7Y]. Outside of the zinc finger, the rest of that protein configured predominantly as random coil with a small β-hairpin in the COOH-proximal acidic domain (aa 37-61). The remaining interior residues, or
Significance
We describe here the first, to our knowledge, NMR structure of full-length RanGTPase protein. The protein is captured complexed to the Mengovirus Leader (L M ) protein. The pair, once bound, triggers a lethal hyperphosphorylation cascade of nuclear pore proteins, leading to enhanced virus replication and cell death. Structures for L M in multiple phosphorylation states, and as bound by Ran, show induced fit reactive faces that putatively recruit and select relevant exportins and active kinases. Normal Ran cycling is irreversibly disrupted because L M localizes to the RanBP1 site, excluding it from hydrolysis pathways. This unique modulation of Ran effector selection is, to our knowledge, the first structure description of nucleocytoplasmic trafficking perversion by a pathogen protein that targets Ran. Potential applications include antiviral drug targets and cancer cell division therapeutics.
hinge region (aa 23-36), have been mapped as the primary contact point(s) for interactions with Ran, in what is presumed to be an induced-fit binding (15) . In cells or via recombinant proteins, saturation binding with L M is best achieved when Ran is aided by catalytic amounts of its cognate guanine nucleotide exchange factor 1 (RCC1), allowing it to morph between GTPand GDP-bound conformers (3) . Complicating a resolution of the full L-dependent antiviral mechanism are observations that L E is itself phosphorylated during EMCV infection, in sequential reactions with casein kinase 2 (CK2) and spleen tyrosine kinase (Syk) at residues T 47 and Y 41 , respectively (16). Although not required for Ran interactions, the L E modifications are clearly important to the virus because mutation at these same sites prevents subsequent Nup phosphorylation (5), suppresses NF-κB activation, and restricts infection-dependent IFN I stimulation (IRF-3 inhibition) (10) (11) (12) .
The initial solution structure of L M did not indicate how phosphorylation might affect the conformation of this protein, influence Ran binding, or contribute to activity of the Ran:L M complex. Accordingly, we carried out, matched NMR studies on the unphosphorylated (L M 0P), singly phosphorylated (L M 1P, T 47 ), and doubly phosphorylated (L M 2P, Y 41 /T 47 ) variants of recombinant L M . In addition, the solution structures of L M (labeled) as bound to Ran (unlabeled) and of Ran (labeled) as bound to L M (unlabeled) were resolved by NMR and docked to each other. The combined datasets clearly define the Ran:L M interfaces available for ternary interactions. Pull-down assays with GST-L M and mutant phosphorylation derivatives, combined with previously resolved structures of Ran binding partners, predict the L M phosphorylation interface, and the L M zinc finger mediate Ran's selection of exportins like Crm1 or CAS and their respective (kinase?) cargos.
Results L E Phosphorylation Sites. The L E (EMCV) and L M (Mengo) proteins differ by a single substitution (L 14 vs. M 14 , respectively), but at the nucleotide level, convenient restriction sites make it easier to manipulate L E rather than L M sequences. The zinc finger motif of L M has been described by NMR (14) , but before extending this work to the fully phosphorylated protein, it seemed prudent to confirm the kinase specificities. A panel of 12 GST-L E proteins was prepared, with alterations at every Thr and Tyr residue. The double mutation Y 41 F/T 47 A was also included. The data, summarized in Table S1 , confirmed previous reports (16) that CK2 uniquely recognizes T 47 . This reaction is an obligate prerequisite to the single-site Syk phosphorylation at Y 41 , a requirement that can be bypassed only if T 47 position is substituted with a phosphomimetic aspartate (T 47 E) or glutamate (16) . The lack of phosphorylation at the Y 41 /T 47 mutated sites is not due to protein misfolding (15) .
L M NMR Determinations. Previous attempts to determine an L M solution structure were confounded by contaminant heavy metals with affinity for the protein acidic domain (14) . The problem was solved by treating samples with EDTA after the removal of the GST tag and then refolding by gradual addition of ZnCl 2 . Dialysis removed exogenous zinc, a requirement for subsequent cosolubility with Ran. The preferred recombinant configurations extended the native L M sequence (67 aa) by 4 aa (Gly-Ser-Thr-Ala) at the amino terminus (Fig. 1) 15 N-NOESY, and 3D 13 C-NOESY spectra, using CARA analysis to verify sequential connectivity. For all proteins, backbone resonance assignments could be obtained for 100% of the 71 residues. The buffer conditions required for solubility, elevated the 31 P background signals to the extent that these particular peaks had to be normalized to maximum resonance levels to obtain good resolution. No abovebackground 31 P signal was identified in L M 0P protein samples, confirming that bacterial expression did not add phosphates. After treatment with CK2 or CK2/Syk, one or two additional major 31 P peaks were identified for L M 1P and L M 2P, at high resolution in isolated 1D 31 P ppm spectral regions, confirming the MS results showing that >80% of L M 1P was phosphorylated and >60% of L M 2P was doubly phosphorylated. The resolution statistics for all three proteins are summarized in Table 1 . Fig. S5B shows restraints per residue. Tables S2 and S3 record determined values for distance restraint reliabilities and structure quality. The 10 lowest energy structures for L M 0P, L M 1P, and L M 2P are deposited in PDB (ID codes 2MMH, 2MML, and 2MMK). Their corresponding data are available from Biological Magnetic Resonance Bank (BMRB) (accession nos. 19084, 19858, and 19857) . The bound zinc ion was modeled into the structures.
L M 0P/1P/2P Comparisons. In the residue numbering for recombinant L M (native +4), the zinc finger (aa 14-26), hinge region (aa 35-45), and acidic domain (aa 41-65) form phenotypic landmarks defined by mutagenesis studies (15) . T 51 and Y 45 are the phosphorylation sites (16) . When L M 0P, L M 1P, and L M 2P were superimposed, the overall root mean square deviation (RMSD) was 12.8 Å for all backbone atoms. The majority of L M 0P was random coil, interspersed with four short helical segments (Figs. 1 and 2 A and B). As defined by TALOS+ algorithms (17) , the α1 and α2 segments (aa 23-26 and 29-31) spanned the COOH-half of the zinc finger. The α3 and α4 motifs, in the hinge region (aa 45-49) and near the COOH tail (aa 63-66), were less well defined. Surprisingly, when one or two phosphates were added, the overall proteins still configured largely as random coil ( Fig. 1 and Fig. S6 B-D) . Superimposed the L M 1P (Fig. 2 C and D) and L M 2P (Fig. 2 E and F) C) and unlabeled proteins were analyzed in parallel, under identical conditions to the single L M determinations. The native (unbound) solution structure of nucleotide-free Ran will be described in detail elsewhere (PDB ID code 2MMC and BMRB accession no. 19852). This dataset aided the assignment of 100% of the 216 Ran resonance peaks from the docked complex(es). The resolution statistics for Ran:(L M 0P) are summarized in Table 1. Tables S2 and S3 record determined values for distance restraint reliabilities and structure quality.
The 10 lowest energy states for Ran, as bound by L M 0P (PDB ID code 2MMG and BMRB accession no. 19854) showed a sixsheet β-propeller core structure, interspersed with nine α-helices (Fig. 3C ), characteristic of other described crystal structures (18, 19) . Relative to each other (Table S4) , the core states (aa 8-176) were tight (RMSD, 0.3 Å), but the full protein value (RMSD, 4.6 Å) was higher because the COOH-tails (aa 177-216) in each state displayed as flexible, floppy arches (Fig. 4A ). All these tails (RMSD, 4.9 Å) had the same central helix (aa 196-206), but none were similarly oriented relative to the core. Among Ran structures solved by crystallography, the COOH tail arrangements can vary according to nucleotide status and binding partner-induced shifts that may also involve the nucleotideproximal phosphate binding P-loop (aa [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , Switch 1 (aa 32-45), Switch 2 (aa 66-79), and basic patch (aa 139-142) internal core segments ( All values were generated by CYANA for structure determination before Xplor-NIH refinement. Reported RMSD values rounded to 0.1 Å. To best describe the solution structure of Ran as bound by L M 0P, the state-1 coordinates were aligned pairwise with representative PDB entries (Table S4) . Only a few such structures have resolved COOH tails, so it was not unexpected that the full-length comparisons (all), or comparisons specific for this region (COOH), showed variability (RMSD, ∼1.5-12.5 Å). The core region comparisons, however, more closely aligned Ran:(L M 0P) with the known GTP-dependent conformers (RMSD, ∼1.5 Å) as opposed to GDP-or nucleotide-free forms (RMSD, ∼3.9 Å). Among these, the core coordinates of PDB ID code 1K5G fit the Ran:(L M 0P) state-1 to a remarkable degree. The overall RMSD (0.4 Å) between these structures showed very low variability in all backbone residues, including the P-loop (0.2 Å), Switch 1 (0.3 Å), and Switch 2 (0.3 Å) segments. This particular dataset and the closely related PDB ID code 15KD entry describe Ran in complex with auxiliary factors RanBP1 and RanGAP, in a GTP-ground state and in a hydrolysis transition state mimic (21) . The NMR solution structure of Ran, as bound by L M 0P, exhibits essentially the same core coordinates. C protein labels were switched in Ran:L M 0P complexes, the states of L M 0P as influenced by Ran showed multiple peak shifts relative to free L M 0P ( Fig. 1 and  Fig. S3A ). The shifts included all residues in the hinge region, as had been anticipated from mutagenesis mapping (15) . Also involved were regions from the carboxyl third of the protein. The zinc finger region did not change, maintaining the α1 and α2 helices. However, as with both phosphorylation datasets, the rest of (Ran):L M 0P now became more compact (Fig. 4B) . The 10 low-energy states (PDB ID code 2MMI and BMRB accession no. 19855) remained predominantly random coil, with an average RMSD of 4.6 Å for backbone atoms. The fit with Ran was clearly induced by mutual binding.
The state-1, low-energy coordinate sets for Ran:(L M 0P) and (Ran):L M 0P were evaluated for fit according to GRAMM-X (22) and HADDOCK algorithms (23) without specified constraints. Previous (pseudo) dockings (15) pairing the initial solution structure of L M (PDB ID code 2M7Y) with Ran (PDB ID code 1K5G) predicted the interactions at the Ran:BP1 binding face with the Ran COOH tail wrapping around L M 0P to hold it firmly onto this surface. The real solution structures indeed followed this pattern. For the HADDOCK outputs, the best cluster (models 1-4) had an RMSD of 0.5 Å, with an E-total of 305-343 kcal/mol for the interface. As depicted in the optimal energy model (model 1), L M 0P sits tightly on the top surface of Ran, without altering the Ran core, or approaching the nucleotide binding pocket ( Fig. 4C and Fig. S6 ). The L M 0P hinge and acidic domains interact significantly with the proximal tip of the Ran COOH tail (aa 203-210), but the remainder of this segment is free to arch without steric hindrance, morphing and encircling central interaction residues of L M 0P (Fig. 4D) (Fig. 4E) . These protein placements are fully consistent with both determined Ran:(L M 0P) and (Ran):L M 0P NMR datasets and all resonance shifts relative to the unbound proteins (Tables S2 and S3 ). It explains the low RMSD for the core of bound Ran, flexibility of the Ran COOH tail, and requirements that the L M 0P zinc finger domain make no contacts with Ran that would prevent it from folding like the native L M 0P protein. In this configuration, both L M 0P phosphorylation sites are solvent exposed on the same face as the zinc finger, even though the loops which display and orient them form key Ran contacts. 
Discussion
Cardiovirus L proteins are extraordinarily toxic to cells because their presence triggers massive hyperphosphorylation of Phe/Gly nuclear pore proteins (Nups). In cell-free assays with intact nuclei, within 5 min of the introduction of recombinant L E -GST (or GST-L E ), there is complete inhibition of all active import and export of host proteins and RNA through the nuclear pore complexes (NPCs) (24) . The discovery that L E bound RanGTPase, the key regulator of nucleocytoplasmic trafficking (NCT), raised the initial possibility of putative stoichiometric inhibition. This idea was quickly discarded because Ran is an abundant protein (25) , and only tiny amounts of L E are required to trigger this effect. Instead, Ran:L E binding is leveraged by consequent activation of a potent Nup phosphorylation cascade, the true cause of trafficking inhibition. This inhibition happens in infected cells even before the virus begins to replicate (6, 26) . The cascade involves Erk1/2 and p38 kinases and is absolutely dependent on Ran:L E interactions and also on the dual phosphorylation of L E itself, an activity that is a prerequisite, and not a consequence, of the Nup modifications (7, 10, 15, 16, 27) . Furthermore, the L E zinc finger motif must remain intact and chelated to the metal for the protein to function (11) . These points were clearly established with extensive activity assays, mutagenesis, and biochemical studies. Because neither L E nor Ran is a kinase, an obvious ensuing step must involve recruitment of one or more critical ternary/ quaternary partners. The identification of these elements is underway. We are focusing on plausible pathways by which Erk1/2 and p38 can be diverted from their normal activities to act on Nups. However, because native Ran has many interaction partners, and L E must be phosphorylated, sorting out precise steps is complicated. To aid in this process, as described here, we resolved the NMR solution structures of L M , its phosphorylated derivatives, and the Ran:L M 0P complex. The studies had three goals: (i) determine whether phosphorylation significantly altered the structure of L M ; (ii) determine the format of Ran as bound by L M , so that germane native binding partners could be evaluated; and (iii) determine the segments of L M , not impacted by Ran, and therefore accessible to later interactions.
The L M (0P/1P/2P) datasets showed this protein, in a free format, does not have a very organized secondary structure, except for the zinc finger domain (Fig. S6) . Phosphorylation provided important constraints on the degree of random coil motion but did not by itself induce an overt restricted format. If conformation plays a role in L M activity, outside of the zinc finger, it must be induced by the relevant binding partners. Indeed, when bound to Ran, L M 0P condensed and made specific contacts in the central hinge and acidic domains, via the same residues identified by mutagenesis (15, 24) . Surprisingly, however, the amino third of the protein, including the zinc finger, and both internal phosphorylation sites were left solvent exposed. It was not expected that all these sites would localize to the same exposed face.
The Ran:L M 0P complex is the first solution structure for Ran and the first to describe the intact full-length protein. At least 45 Ran datasets have been collected and resolved by crystallography, but in almost all cases, 4-9 amino-terminal residues and >40 carboxyl-terminal residues are unresolved or were not included in the determinations. The entries differ in nucleotide-bound status and coresolution of diverse transport-related binding partners. By NMR, it was clear that L M 0P binding induced a Ran conformer almost identical to that assumed when Ran binds to BP1, a cytoplasmic auxiliary factor (e.g., PDB ID code 1K5G). Although the Ran:(L M 0P) complex was nucleotide free, the P-loop, Switch 1, and Switch 2 regions were set to the typical GTP formats, as they would be naturally, whenever Ran exits the nucleus, usually bound to an exportin, and makes initial cytoplasmic contacts with BP1 and RanGAP (21) . L M and BP1 do not share sequence similarity, yet on Ran, they occupy similar footprints and their binding is mutually exclusive (24) . Not captured by crystallography, but very apparent by NMR, was the dynamic morphing of the Ran COOH tail over the top of this binding partner face. L M 0P made important contacts with the beginning and end of this segment, but the resolved states recorded considerable movement here for both proteins.
How then does this conformation allow the Ran:L M complex to form its next interactions? Complete phosphorylation by CK2 (T 51 ) and Syk (Y 45 ) have been demonstrated after the pair is bound (16) . The observed proximity of these sites to the zinc finger, as with the solution structures of L M 1P and L M 2P, might conceivably influence the rigidity or orientation of this domain when bound to Ran. More likely, it is a combination of all these factors on this exposed L M face, working with Ran, now locked in a GTP format, that select the next partner. Our preliminary experiments suggest exportins, like Crm1 or CAS, are likely candidates. L E -GST can extract both native proteins from HeLa cell extracts in reactions that show a strong dependence on the L E phosphorylation status (Fig. 5 ). Mutations in either or both of the phosphorylation sites diminished the L E binding. However, because these pull-downs are from extracts, it is not yet known whether similar exportin:L E interactions are codependent, obligate, or independent of simultaneous Ran:L E reactions. To work this out experimentally will require considerable validation of stepwise protocols, including the sequential addition of phosphates, the proper nucleotide status of Ran, demonstration of an active exportin conformation, and putative cargo inclusion.
As a guide for these parameters, we used molecular replacement algorithms to test a putative Ran:L M 0P docking into the context of a determined Ran:Crm1:cargo structure. The selected template (PDB ID code 3GJX) included snurportin1 as the Crm1 cargo (28) . Obviously snurportin is not relevant to the Erk1/2 and p38 Nup phosphorylation pathways, but its location helps orient the participants. When native Ran binds an exportin, it must be in the GTP format (29) , as it is for Ran:L M 0P, albeit in our complex, the nucleotide status is forced artificially by the L M 0P protein interactions. Substitution of the NMR-determined Ran:L M 0P for the crystallographically determined Ran into this structure (Fig.  4F ) did not create steric clashes. All described Ran:Crm1 contacts were maintained (Table S4 ; PDB ID code 3GJX), and even each of the morphing NMR derivatives of the Ran COOH tail were without conflicts. Of importance, this enforced orientation of L M 0P placed the phosphorylation and zinc finger face into the immediately
Exportin pulldown by L E -GST. L E -GST proteins (or GST alone) were incubated with HeLa cell cytosol then reacted with glutathione-conjugated beads in assays identical to those previously described (24 
Materials and Methods
L E and L M Proteins. Recombinant L E -GST (EMCV) and mutated derivatives were expressed and purified from Escherichia coli as previously described (6, 15, 24) . GST-L M (Mengo) has also been previously described (14) . The protein includes a thrombin cleavage site for GST-tag removal. Uniform, dual labeled [
C]-L M 0P was produced from BL-21 (DE3) cells transformed with pGST-L M. The required media, induction procedures, protein isolation (GST Trap column), removal of the GST tag, gel filtration, concentration, EDTA treatment, and refolding by dialysis are detailed in SI Materials and Methods. Protein purity (>95%) was determined by SDS/PAGE followed by silver stain. Phosphorylation with CK2 alone (L M 1P) or CK2 followed by Syk (L M 2P) is described in SI Materials and Methods. All labeled or unlabeled materials were assayed for molecular weight (SDS/PAGE, MALDI-MS), proper folding by 1 H spectra (15) , and biological activity (24) before structure determination.
Ran Proteins. Plasmids encoding Hexa-His-Xpress tagged human Ran GTPase (His-Xp-Ran) were a gift from Mary Dasso (National Institutes of Health, Bethesda, MD). Unlabeled protein, as expressed in BL21 cells, was as previously described (15 C] preparations were similar to L M 0P, except for the inclusion of ampicillin (50 μg/mL) in the medium. Ran purification, as summarized in SI Materials and Methods, has been previously described (15) , but then, if for use in NMR, the samples were treated with EDTA (5 mM, 30 min, 25°C) and dialyzed (2 h, 25°C) into NMR buffer (2 L), followed by a second dialysis into fresh NMR buffer (overnight, 4°C). Ran prepared this way (259 aa) retains the expression tag (43 aa) at the amino terminus of the full-length protein (216 aa). Recombinant GST-RCC1 (Xenopus laevis) was purified as previously described (30) and then dialyzed into NMR buffer. P three-axis gradient cryogenic probe. The techniques and algorithms used to process the raw data are detailed in SI Materials and Methods. The information includes a process workflow chart (Fig. S1 ) backbone and side-chain assignments (Figs. S2  and S4 ), dihedral angle constraint files (Figs. S3 and S5B ), structure calculations, nonstandard amino acids identification, motif location, processing command lines (Dataset S1), and data refinement (Fig. S5A ). The quality of each generated structure (Table S3 ) was analyzed for restraint and geometry violations using the Duke University MolProbity web server (31, 32) . The NMR restraints and structural statistics (Table 1) were generated by CYAN before Xplore-NIH refinement (33) . All L M datasets (71 aa) recorded the (4 aa) amino-terminal extensions. The Ran datasets omitted tag-related peaks and numbered the protein (216 aa) according to its native sequence. The lowest energy NMR states for L M 0P and Ran from the docked complexes were submitted to HADDOCK via the public web portal (23) . No constraints were specified. Docking interfaces for the lowest energy complex were evaluated online using PDBePISA resources (www.ebi.ac. uk/pdbe/pisa/) and the Protein Interactions Calculator (PIC) (34) . (1-3) . Each protein was dialyzed into buffer [25 mM Hepes (pH 7.3), 150 mM KCl, and 2 mM DTT] and stored at −80°C. Concentrations were determined with BCA protein assay kits (Thermo Scientific). The cell-free phosphorylation assays were essentially as previously described (4) . GST (85 pmol) or GST-L E (85.71 pmol) was incubated with buffer alone, CK2 (10 U; New England Biolabs), or CK2 (10 U) plus Syk (10.3 U; SignalChem) in the manufacturers' reaction buffers supplemented with 5.0 μCi [γ-32 P] ATP (3,000 Ci/mmol, 10 mCi/mL). After incubation at 37°C for 60 min, samples were loaded for SDS/ PAGE fractionation. To evaluate the Syk (only) reactions, the proteins were pretreated with CK2 and (cold) ATP before the addition of Syk and [γ-
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32 P] ATP. The resolved gels were silver stained and then exposed to phosphor screens for band visualization (GE Healthcare). 13 C -D-glucose (wt/vol), 50 μg/mL kanamycin, pH 7.3] before induction with isopropyl-β-D-thiogalactopyranoside (IPTG, 1 mM). Cells were collected at an OD 600 of 2.7-3.2. Harvest was on GSTrap FF columns, where the GST tags were removed before elution by reaction with thrombin protease as previously described (3). The affinity chromatography was followed by gel filtration using a Sephacryl S-100 column (GE Healthcare) and finally anion exchange with a Mini Macro-Prep High Q cartridge (Bio-Rad). The protein was concentrated using an Amicon Ultracentrifuge device (Millipore), treated with 0.25 mM EDTA for 5 min at 25°C and then refolded by dialysis (2 L, 20 mM Hepes, pH 7.5, 100 mM KCl, 2 mM DTT, 0.25 mM ZnCl 2 , 12 h, 4°C). The protein was then dialyzed twice more into NMR buffer (20 mM Hepes, pH 7.5, 150 mM KCl, 2 mM MgCl 2 , 5 mM DTT, 0.04% NaN 3 , 12 h, 4°C) before storage at −80°C. The molecular weight of [
C]-L M 0P was determined by matrix-assisted laser desorption ionization-MS (MALDI-MS) using a Bruker BIFLEX III mass spectrometer. Protein purity (>95%) was determined by SDS/PAGE followed by silver stain. Care was taken at all steps to use NMR-grade, metal-free reagents. ) was dialyzed (10 mM BisTris propane, pH 7.4, 50 mM NaCl, and 2 mM DTT) and purified by anion exchange using a Mini Macro-Prep High Q cartridge (Bio-Rad) over a 20-column volume salt gradient (50-500 mM NaCl) to remove the kinases. The proteins were treated with 0.25 mM EDTA for 5 min at 25°C, refolded (as above), dialyzed into NMR buffer (as above), and then stored at −80°C.
Ran for NMR. Plasmids encoding Hexa-His-Xpress-tagged human Ran GTPase (His-Xp-Ran) were a gift from Mary Dasso (National Institutes of Health, Bethesda, MD). Unlabeled protein was expressed in BL21 cells as previously described (3 C]-L M , with 50 μg/mL ampicillin instead of kanomycin. Initial protein purification steps (labeled or unlabeled) were as previously described (3), using a two-tier process of HisTrap HP (GE Healthcare) affinity chromatography followed by gel filtration using a Sephacryl S-100 column (GE Healthcare). If for use in NMR, the samples were treated with EDTA (5 mM, 30 min, 25°C) and dialyzed (2 h, 25°C) into NMR buffer (2 L, 20 mM Hepes, pH 7.4, 100 mM KCl, 2 mM MgCl 2 , 2 mM DTT, and 0.04% NaN 3 ), followed by a second dialysis into fresh NMR buffer (overnight, 4°C). Care was taken at all steps to use NMR-grade, metal-free reagents. Ran prepared this way (259 aa) retains the expression tag (43 aa) at the amino terminus of the full-length protein (216 aa). Recombinant GST-RCC1 (X. laevis) was purified as previously described (6) and then dialyzed into NMR buffer. 15 N-NOESY (t mix = 120 ms), and 3D 13 C-NOESY (t mix = 120 ms) were collected on a Bruker DRX-600 spectrometer equipped with an 1 H, 13 C, 15 N, 31 P three-axis gradient cryogenic probe. Standard NMR terminology includes NOESY (nuclear Overhauser effect spectroscopy), NHCABA (carbon alpha, carbon beta, amide spectroscopy), CBCA(CO)NH (carbon beta, carbon alpha, carbonyl spectroscopy), HSQC (heteronuclear single quantum coherence spectroscopy), TOCSY (total correlated spectroscopy), CARA (computer-aided resonance assignment).
Data Processing. Fig. S1 shows a summary flowchart for all data manipulations. The collected NMR data were processed using NMR-Pipe software (7), followed by peak picking and spin-system determination with CARA software (8) . Cross-reference of 15 N-HSQC, 13 C-HSQC, CBCACONH, HBHACONH, CCONH, HCCONH, and HCCH-TOCSY spectra from uniformly labeled 15 N/ 13 C proteins assigned backbone and side-chain atoms (e.g., Figs. S2 and S4). TALOS+/RAMA+ generated dihedral angle constraint files (9) for input into CYANA (10) for structure calculations (Figs. S2 and S5B ). The -ref comment alongside X-raydetermined structures of Ran generated upper and lower references for TALOS+ dihedral angle constraints in conjunction with chemical shifts assignments for NMR-resolved Ran (PDB ID code 2MMC) and Ran:(L M 0P). Cross-correlation of 3D HCCH-TOCSY, 13 C-NOESY, and 15 N-NOESY spectra, collected using a mixing time set to 120 ms for all triple-labeled data acquisition, assigned NOESY connectivity with CARA, SPARKY, CYANA, and CSRosetta (8, (10) (11) (12) (13) (14) . Nonstandard amino acids and refinements (Table S3) were finalized by using VMD-X-PLOR (15) . The quality of each generated structure was analyzed for restraint and geometry violations using the Duke University MolProbity web server (16, 17) . All L M datasets (71 aa) recorded the (4 aa) amino-terminal extensions. The Ran datasets omitted tagrelated peaks and numbered the protein (216 aa) according to its native sequence. Additional information for many of these technical processes is presented in the next sections. (18), with the addition of an evolution period during 2D
15 N-HSQC data collections.
NMR-PIPE NOESY Processing. The command lines used to process 15 N/ 13 C-NOESY spectra following data collected on a 600-MHz Bruker spectrometer are provided in Dataset S1.
Dihedral Angle Constraints. Residue atoms were manually assigned using CARA (8) . CARA wrote *.tab files for input into TALOS+/ RAMA+, which generated de novo *.aco dihedral angular constraints and secondary structure element files. Peak lists and peak tables were imported from CARA into SPARKY (11) for figure visualization and assignment verification with PINE-SPARKY (19) .
Automatic CYANA NOESY Assignments with CS-Rosetta Convergence.
Structure calculations were conducted by running CYANA 3.0 (e-NMR) with peak intensities from three NOESY spectra: TALOS+ dihedral angle constraints, residual decoupling restraints, and initial, manually assigned NOE restraints as input files (10) . After several runs using TALOS+-derived dihedral angle constraints and increasingly convergent high-quality CS-Rosetta and CYANA-derived NOE restraints, final automated NOESY assignments were generated in CYANA with the seeding NOEs. Blind CS-Rosetta structure determination was also conducted with final CYANA-derived dihedral angle and NOE constraint files (14) . CS-Rosetta models were similar to CYANA-determined structures. For the L M structures, the 10 final CYANA-generated coordinate sets (10) were too dynamic for PDB deposition, so in each case, the low energy model 1 was further examined with the Xplor-NIH package NAMD (15) energy minimization and collective variable analysis (PLUMED) to calculate the final, refined 10 states that were compatible with and deposited at PDB.
Structure Generation Using CYANA. TALOS+ *.aco torsion angle constraint files, CYANA-derived *.upl residual dipolar coupling, distance restraint files, and final assigned NOESY peak lists were used as input into CYANA to calculate 50 structures to output the 10 final low-energy states. Combinations of random restraints were used to improve structure qualities as above and as previously detailed (14) . PRO-CHECK and AQUA through ADIT-NMR were used to validate the final 10 NMRdetermined PDB-deposited structures (20) .
Docking and Bioinformatics. TALOS+ algorithms (7) were used to define α and β motifs within the determined structures (Fig. S5) . The lowest energy NMR states for L M 0P and Ran, as determined from the docked complexes, were submitted to HADDOCK via the public web portal (21) . No constraints were specified. Docking interfaces for the lowest energy complex were evaluated online using PDBePISA resources (www.ebi.ac.uk/pdbe/pisa/) and the PIC (22) . RMSDs for comparative states or pairwise structures used the "align" function of PyMol (23), specifying only the backbone c+n+ca+o atoms (Table S4 ). Structure display was by PyMol or Chimera (24) . Summary of NOESY cross-peaks used in L M 0P and Ran:(L M 0P) assignments with CYANA. Columns indicate cross-peaks for each respective group. CYANA semiautomated peak picking followed initial manual assignments. CYANA-generated NOE distance restraint reliabilities fell from 0 to 1. Combinations of random restraints were used to improve structure qualities as previously detailed (14) . *Long-range restraints ji-jj ≥ 5. † SUP, reliability of constraints as assigned by CYANA from 0 to 1. 
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